• EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research

      Seppala, L J; van der Velde, N; Masud, T; Blain, H; Petrovic, M; van der Cammen, T J; Szczerbinska, K; Hartikainen, S; Kenny, R A; Ryg, J; et al. (Springer, 2019-02)
      Key summary pointsFalls are under-recognized as adverse drug events.Healthcare professionals are reluctant to withdraw fall-risk-increasing medications.The EuGMS Task and Finish group on fall-risk-increasing drugs (FRIDs) proposes in this paper its recommendations on dissemination of knowledge about, management of, and future research on FRIDs. AbstractFalls are a major public health concern in the older population, and certain medication classes are a significant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor. In the present statement, the European Geriatric Medicine Society (EuGMS) Task and Finish group on fall-risk-increasing drugs (FRIDs), in collaboration with the EuGMS Special Interest group on Pharmacology and the European Union of Medical Specialists (UEMS) Geriatric Medicine Section, outlines its position regarding knowledge dissemination on medication-related falls in older people across Europe. The EuGMS Task and Finish group is developing educational materials to facilitate knowledge dissemination for healthcare professionals and older people. In addition, steps in primary prevention through judicious prescribing, deprescribing of FRIDs (withdrawal and dose reduction), and gaps in current research are outlined in this position paper.
    • Tardy development of safe medicines for children: a Nordic network offers new platform to reduce this inequity.

      Naumburg, Estelle; Rane, Anders; Halvorsen, Thomas; Glosli, Heidi; Henriksen, Tine Brink; Haraldsson, Àsgeir; Kallio, Jaana; Lepola, Pirkko; 1 Department of Clinical Science, Paediatrics, Umeå University, Umeå, Sweden. 2 Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital (Huddinge site), Stockholm, Sweden. 3 Department of Clinical Science, University of Bergen, Bergen, Norway. 4 Department of Paediatrics, Haukeland University Hospital, Bergen, Norway. 5 Institute for Paediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. 6 Perinatal Epidemiology Research Unit, Deptartment of Paediatric and Adolescent Medicine, Aahus University Hospital, Aahus, Denmark. 7 Faculty of Medicine, Children's Hospital, University of Iceland, Landspítali - University Hospital, Reykjavik, Iceland. 8 Department of Children and Adolescents, Helsinki University Hospital, Helsinki, Finland. (Wiley, 2019-06)